Table 5.
Treatment site | Action Level μ ± 2σ (%) | Tolerance level μ ± 3σ (%) |
---|---|---|
Prostate | 1.6 ~ 3.4 | 1.1 ~ 3.8 |
Head and neck | −0.1 ~ 2.3 | −0.7 ~ 2.9 |
Esophagus | 0.1 ~ 3.1 | −0.7 ~ 3.9 |
OAR | −0.9 ~ 1.8 | −1.6 ~ 2.5 |
Treatment site | Action Level μ ± 2σ (%) | Tolerance level μ ± 3σ (%) |
---|---|---|
Prostate | 1.6 ~ 3.4 | 1.1 ~ 3.8 |
Head and neck | −0.1 ~ 2.3 | −0.7 ~ 2.9 |
Esophagus | 0.1 ~ 3.1 | −0.7 ~ 3.9 |
OAR | −0.9 ~ 1.8 | −1.6 ~ 2.5 |